Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
23andMe Holding (ME)
NASDAQ:ME
Holding ME?
Track your performance easily
ME Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.66 - $19.19
Previous Close$3.3
Volume225.08K
Average Volume (3M)341.31K
Market Cap
$90.20M
Enterprise Value-$5.63M
Total Cash (Recent Filing)$170.00M
Total Debt (Recent Filing)$74.16M
Price to Earnings (P/E)―
Beta1.86
Next Earnings
Feb 05, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-25.27
Shares Outstanding26,117,997
10 Day Avg. Volume379,569
30 Day Avg. Volume341,305
Standard Deviation0.17
R-Squared0.12
Alpha-0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.60
Price to Sales (P/S)0.74
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.04
Enterprise Value/Gross Profit-0.06
Enterprise Value/Ebitda0.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
23andMe Holding News
PremiumCompany Announcements
23andMe Reports Improved Financial Metrics Amid Revenue Decline
PremiumCompany Announcements
23andMe Regains Nasdaq Compliance and Ensures Listing
Ownership Overview
49.38% Insiders
8.52% Mutual Funds
0.42% Other Institutional Investors
36.96% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
The estimated number of people who visited one or more of the websites owned by 23andMe Holding
Desktop Users
Mobile Users
ME FAQ
What was 23andMe Holding’s price range in the past 12 months?
23andMe Holding lowest stock price was $2.65 and its highest was $19.19 in the past 12 months.
What is 23andMe Holding’s market cap?
Currently, no data Available
When is 23andMe Holding’s upcoming earnings report date?
23andMe Holding’s upcoming earnings report date is Feb 05, 2025 which is in 36 days.
How were 23andMe Holding’s earnings last quarter?
23andMe Holding released its earnings results on Nov 12, 2024. The company reported -$2.32 earnings per share for the quarter, beating the consensus estimate of -$3.152 by $0.832.
Is 23andMe Holding overvalued?
According to Wall Street analysts 23andMe Holding’s price is currently Overvalued.
Does 23andMe Holding pay dividends?
23andMe Holding does not currently pay dividends.
What is 23andMe Holding’s EPS estimate?
23andMe Holding’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 23andMe Holding have?
23andMe Holding has 19,011,873 shares outstanding.
What happened to 23andMe Holding’s price movement after its last earnings report?
23andMe Holding reported an EPS of -$2.32 in its last earnings report, beating expectations of -$3.152. Following the earnings report the stock price went up 2.169%.
Which hedge fund is a major shareholder of 23andMe Holding?
Among the largest hedge funds holding 23andMe Holding’s share is Graham Capital Management, L.P.. It holds 23andMe Holding’s shares valued at 55K.
---
23andMe Holding Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ME Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-81.70%
12-Months-Change
Fundamentals
Return on Equity
-169.23%
Trailing 12-Months
Asset Growth
-60.19%
Trailing 12-Months
Company Description
23andMe Holding
VG Acquisition Corp is a blank check company.
---
ME Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative developments. While there were significant achievements in board reconstitution, subscription service growth, and improved financial metrics, the company faced challenges with revenue decline, discontinuation of therapeutic programs, and financial liquidity concerns.Read More>---
ME Revenue Breakdown
100.00% Consumer & Research Services
0.00% Therapeutics
---
ME Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ME
1 Year
1 Year Success Rate
0/6 ratings generated profit
1 Year Average Return
-68.75%
reiterated a buy rating 5 months ago
Copying Steven Mah's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -68.75% per trade.
---